Design and application of HSV vectors for neuroprotection. - Wikidata - wikimedia - TriplyDB

Design and application of HSV vectors for neuroprotection.

Design and application of HSV vectors for neuroprotection.

http://www.wikidata.org/entity/Q33837131

about

Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin Gene therapy in wound repair and regeneration.Delivery of novel macromolecular drugs against HIV-1.Viruses as gene delivery vectors: application to gene function, target validation, and assay development.Neuroprotective gene therapy against acute neurological insults.Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy.Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.Gene therapy for the treatment of sensory neuropathy.Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception Gene therapy for the treatment of diabetic neuropathy.Targeted drug delivery to the peripheral nervous system using gene therapy.Viral oncoapoptosis of human tumor cells.Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells.Gene therapy in the treatment of lower extremity wounds.An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4.HSV-1 as a Model for Emerging Gene Delivery Vehicles

P2860

Q33792025-DC1BAAE6-056A-4DD4-87D3-80FFB326F5E5 Q34156741-20912CCF-67BF-49D2-8C18-145B30707EEF Q34452681-E6A33471-0C3A-41D5-B15F-26BBB4280E1D Q34756836-810DCFD1-5C66-4255-95FA-A9DE901EC2F8 Q35038275-B87E51A5-BDC0-476E-AED8-7BDA4E27EBE8 Q35131218-D84E99A0-F827-4E7E-8F12-25122F98286D Q35594068-4F07263B-BC0C-4F08-BEA8-FCBFA040D0F3 Q36446943-EC288B29-6DB8-4F43-85B6-FC3358F62174 Q36634794-2534483E-BE41-4F05-A65F-EE0777C3F292 Q37319721-A3131F97-7A3D-4EC2-B329-943854835376 Q38008125-63BF5501-CC5D-4861-ADEC-225AF15022ED Q45864370-61D6A2EA-A180-4C45-9245-A10341572B9B Q45875123-DCB39F89-7649-4FB6-BED2-589298A7F27E Q45883172-39585F6C-80D3-4055-A605-B2C891CC93EA Q54264680-047E8A01-2ACD-4648-B2C1-DAD1D32EB38A Q58995392-500CA4B3-8D1A-448D-BA5F-374E31CDD76E

P2860

Design and application of HSV vectors for neuroprotection.

http://www.wikidata.org/entity/Q33837131

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Design and application of HSV vectors for neuroprotection.

@ast

Design and application of HSV vectors for neuroprotection.

@en

type

label

Design and application of HSV vectors for neuroprotection.

@ast

Design and application of HSV vectors for neuroprotection.

@en

prefLabel

Design and application of HSV vectors for neuroprotection.

@ast

Design and application of HSV vectors for neuroprotection.

@en

P1433

Q33837131-194AF36D-FD1C-4505-B48A-86E69CE036B2

P1476

Q33837131-5FC7ED98-ED1F-4FEE-B68D-CBB9D2F875B7

P2093

Q33837131-411D4ECA-DF11-495E-B60D-3DF6FA335B57

Q33837131-469A3646-B68F-4B34-B8EE-A45A88E4ED42

Q33837131-658A3FE8-0E98-48A2-9CB2-26F88FED7297

Q33837131-9E2FECE0-A371-489B-BCC5-A25F79236015

Q33837131-CCD45706-4C57-48DA-B019-B9B5BE489402

P2860

Q33837131-35382859-ED8C-4244-A7EA-67A070F29386

Q33837131-52541B50-AE0E-462E-AADB-2E6F557AA728

Q33837131-5831C5AF-8AB1-4D74-9934-DC5E962E76DC

Q33837131-D342AD50-F517-4F83-BAD5-98670A609DEE

Q33837131-F9A5BB74-0ADA-4A4F-8200-C27B51A68684

Q33837131-FC1F4A45-0099-4C1E-83F5-5C47E74C7633

P2888

Q33837131-90B4091C-3B42-43F0-A01C-A2387B55EFD8

P304

Q33837131-AAAACD5B-A0BE-4350-94AE-5635D816AA4D

P31

Q33837131-1911777C-7207-49FE-904F-3853F33A4B06

P356

Q33837131-65BF13CD-20EE-4CC8-9E32-56DAE859219B

P433

Q33837131-D91D1D27-EF69-4A0F-8DE6-76A76C446A81

P478

Q33837131-6D63F5DD-5319-44C5-87B9-ED4356C4D3E0

P577

Q33837131-E885DD74-67BC-4307-8509-9080851C99BF

P5875

Q33837131-5882EE4E-AA8F-48AB-8102-5392E6D8943C

P698

Q33837131-56FF93D6-AB82-4BE7-8E7E-072752A12D73

P356

P1433

P1476

Design and application of HSV vectors for neuroprotection.

@en

P2093

DeLuca NA

http://www.w3.org/2001/XMLSchema#string

Fink DJ

http://www.w3.org/2001/XMLSchema#string

Glorioso JC

http://www.w3.org/2001/XMLSchema#string

Wolfe DP

http://www.w3.org/2001/XMLSchema#string

Yamada M

http://www.w3.org/2001/XMLSchema#string

P2860

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo

Gene transfer to neurons using herpes simplex virus-based vectors.

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

Establishment of latency in vitro with herpes simplex virus temperature-sensitive mutants at nonpermissive temperature.

P2888

P304

115-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3301118

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12641115

http://www.w3.org/2001/XMLSchema#string

P698

10673716

http://www.w3.org/2001/XMLSchema#string